Improving human health everywhere.
Science without fear.
Seoul Immunogenicity and Tolerance Seminar
March 4th, 2019
EpiVax Gives Back in 2018, Looks Forward to 2019!
Leslie J. De Groot MD, 1928-2018
Breaking News: FDA awards $1 million to EpiVax, CUBRC, to assess generic peptide drugs
PANDA: The Newest Product at EpiVax
EpiVax Oncology Completes a $1.2M Bridge Financing
We take pride in our ability to put our combined intelligence, experience, and creativity to work to improve human health. Open minds, creative thought and natural curiosity lead to paradigm shifts. Contact us today to learn more.
188 Valley Street, Suite 424, Providence, RI 02909 USA
ph: 401.272.2123 fax: 401.272.7562